Allysta
Bellevue
About Allysta
Allysta develops medicines for fibrosing diseases and ocular surface inflammations. They offer anti-inflammatory, anti-fibrotic, cell-regenerative, and beneficial metabolic properties that provide opportunities for development in multiple diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2019)
- Website: allysta.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/allysta-49018 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.